Kathy Dujardin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathy Dujardin has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Luc Defebvre
Service de Neurologie et Pathologie du Mouvement, CHRU, Lille
9 shared publications A. Delval
4 shared publicationsA. Destée
Service de neurologie et pathologie du mouvement, hôpital Roger-Salengro, CHRU de Lille, rue Émile-Laine, 59037 Lille cedex, France; Inserm, UMR 837, Team 6, JPArc, IRCL, 2, avenue Oscar-Lambret, 59037 Lille cedex, France
4 shared publicationsA. Destee
3 shared publicationsLuc Defebvre
Neurologie A, Clinique Neurologique CHU de Lille
3 shared publications- Philippe Derambure
Laboratoire de Physiologie, EA2683, Institut Fédératif de Recherche 114, Faculté de médecine Henri Warembourg, Lille cedex, France
3 shared publications
Latest Publications
- 1 November 2014
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 44 (5) , 503
Comment l’attention visuo-spatiale modifie-t-elle l’initiation du pas ?
- 1 November 2014
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 44 (5) , 503
Comment l’attention visuo-spatiale modifie-t-elle l’initiation du pas ?
- 1 March 2014
- Published by Elsevier in Revue Neurologique
- Vol. 170 (3) , 205-215
Le traitement par apomorphine en perfusion continue sous-cutanée dans la maladie de Parkinson : analyse rétrospective d’une série de 81 patients
- 1 March 2014
- Published by Elsevier in Revue Neurologique
- Vol. 170 (3) , 205-215
Le traitement par apomorphine en perfusion continue sous-cutanée dans la maladie de Parkinson : analyse rétrospective d’une série de 81 patients
- 30 April 2013
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 43 (2) , 110
Troubles du comportement en sommeil paradoxal dans la maladie de Parkinson débutante
- 30 April 2013
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 43 (2) , 110
Troubles du comportement en sommeil paradoxal dans la maladie de Parkinson débutante
- 22 April 2012
- Published by Wolters Kluwer Health in Neurology
- Vol. 78 (Meeting Ab) , S02.004
Methylphenidate for Gait and Attention Disorders in Advanced Parkinsonian Patients with Subthalamic Stimulation: A Multicentric Randomized, Double-Blind, Placebo-Controlled Study (S02.004)
- 22 April 2012
- Published by Wolters Kluwer Health in Neurology
- Vol. 78 (Meeting Ab) , S02.004
Methylphenidate for Gait and Attention Disorders in Advanced Parkinsonian Patients with Subthalamic Stimulation: A Multicentric Randomized, Double-Blind, Placebo-Controlled Study (S02.004)
- 29 February 2012
- Published by Elsevier in Revue Neurologique
- Vol. 168 (2) , 143-151
Troubles du contrôle des impulsions associés à la maladie de Parkinson : étude d’une cohorte de 35 patients
- 29 February 2012
- Published by Elsevier in Revue Neurologique
- Vol. 168 (2) , 143-151
Troubles du contrôle des impulsions associés à la maladie de Parkinson : étude d’une cohorte de 35 patients
- 28 February 2010
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 16, S22
075 MODULATION OF THE RELEASE OF ANTICIPATORY POSTURAL ADJUSTMENTS (APAS) DURING STEP INITIATION: WHAT IS THE ROLE OF ATTENTION?
- 28 February 2010
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 16, S22
075 MODULATION OF THE RELEASE OF ANTICIPATORY POSTURAL ADJUSTMENTS (APAS) DURING STEP INITIATION: WHAT IS THE ROLE OF ATTENTION?
- 29 February 2008
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 14, S24
P1.053 Effect of external cueing on gait in Huntington's disease
- 29 February 2008
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 14, S24
P1.053 Effect of external cueing on gait in Huntington's disease
- 1 January 2007
- Published by Springer Nature in The Cerebellum
- Vol. 7 (2) , 1-5
Slowly progressive spinocerebellar ataxia with extrapyramidal signs and mild cognitive impairment (SCA21)
Spinocerebellar ataxia 21 is a slowly progressive and mild ataxia associated with extrapyramidal signs. Affected subjects exhibit a moderate gait and limb ataxia variably associated with akinesia, tremor, rigidity, hyporeflexia, and mild cognitive impairment. The responsible gene has been assigned to a 19 Mbases interval on chromosome 7p in a single French family. No evidence of significant linkage to this locus was found in 21 other families obtained from the EUROSCA consortium. The locus interval contains several candidate genes that could be responsible for the disease. Direct sequencing of NDUFA4, PHF14, KIAA0960, ARLA4, ETV1, DGKB, HDAC9, FERD3L, ITGB8, and SP4 genes were performed, but all the direct mutation analyses were negative excluding pathogenic mutations associated with the disease. Therefore, the gene responsible for SCA21 remains to be identified.
- 1 January 2007
- Published by Springer Nature in The Cerebellum
- Vol. 7 (2) , 1-5
Slowly progressive spinocerebellar ataxia with extrapyramidal signs and mild cognitive impairment (SCA21)
Spinocerebellar ataxia 21 is a slowly progressive and mild ataxia associated with extrapyramidal signs. Affected subjects exhibit a moderate gait and limb ataxia variably associated with akinesia, tremor, rigidity, hyporeflexia, and mild cognitive impairment. The responsible gene has been assigned to a 19 Mbases interval on chromosome 7p in a single French family. No evidence of significant linkage to this locus was found in 21 other families obtained from the EUROSCA consortium. The locus interval contains several candidate genes that could be responsible for the disease. Direct sequencing of NDUFA4, PHF14, KIAA0960, ARLA4, ETV1, DGKB, HDAC9, FERD3L, ITGB8, and SP4 genes were performed, but all the direct mutation analyses were negative excluding pathogenic mutations associated with the disease. Therefore, the gene responsible for SCA21 remains to be identified.
- 1 May 2003
- Vol. 159, 593-7
[Management of a parkinsonian patient treated by stimulation of the subthalamic nuclei].
- 1 May 2003
- Vol. 159, 593-7
[Management of a parkinsonian patient treated by stimulation of the subthalamic nuclei].
- 1 July 2001
- Published by Springer Nature in Journal of Neurology
- Vol. 248 (7) , 603-611
Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease
Background: The clinical efficacy of chronic deep brain stimulation in the treatment of parkinsonian patients with severe levodopa-related motor adverse effects has been repeatedly shown. Bilateral subthalamic nucleus (STN) stimulation has been shown to present an advantage over pallidal stimulation as it induces a higher antiakinetic effect and has positive effects on all parkinsonian symptoms. The morbidity of such surgery is usually considered to be very low. However, few studies have extensively examined the effects of chronic STN stimulation on cognitive function. Objective: The aim of the present study was to assess the effects of chronic bilateral STN stimulation on performance in an extensive battery of neuropsychological tests, three months and one year after surgery. Methods: Nine patients with Parkinson's disease were selected for STN electrodes implantation. They underwent a neuropsychological evaluation at one month before and at three months after surgery. Six of them were examined again at one year after surgery. Results: Before surgery, no patient showed cognitive decline. At three months after surgery, no modification was observed for most tasks. The information processing speed tended to improve. There was a significant reduction of the performance in a delayed free recall test and a trend toward a significant reduction of categorial word fluency. At one year after surgery, most task measures did not change. Slight impairment was observed for tasks evaluating executive function. Examination of individual results showed that some patients (30 % at 3 months after surgery) showed an overall cognitive decline. Behavioural changes were also observed in 4 patients with overall cognitive decline in one of them. Conclusion: In general, STN deep brain stimulation can be considered as a significant contribution to the treatment of severe Parkinson's disease However, in some patients it can induce overall cognitive decline or behavioural changes.
- 1 July 2001
- Published by Springer Nature in Journal of Neurology
- Vol. 248 (7) , 603-611
Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease
Background: The clinical efficacy of chronic deep brain stimulation in the treatment of parkinsonian patients with severe levodopa-related motor adverse effects has been repeatedly shown. Bilateral subthalamic nucleus (STN) stimulation has been shown to present an advantage over pallidal stimulation as it induces a higher antiakinetic effect and has positive effects on all parkinsonian symptoms. The morbidity of such surgery is usually considered to be very low. However, few studies have extensively examined the effects of chronic STN stimulation on cognitive function. Objective: The aim of the present study was to assess the effects of chronic bilateral STN stimulation on performance in an extensive battery of neuropsychological tests, three months and one year after surgery. Methods: Nine patients with Parkinson's disease were selected for STN electrodes implantation. They underwent a neuropsychological evaluation at one month before and at three months after surgery. Six of them were examined again at one year after surgery. Results: Before surgery, no patient showed cognitive decline. At three months after surgery, no modification was observed for most tasks. The information processing speed tended to improve. There was a significant reduction of the performance in a delayed free recall test and a trend toward a significant reduction of categorial word fluency. At one year after surgery, most task measures did not change. Slight impairment was observed for tasks evaluating executive function. Examination of individual results showed that some patients (30 % at 3 months after surgery) showed an overall cognitive decline. Behavioural changes were also observed in 4 patients with overall cognitive decline in one of them. Conclusion: In general, STN deep brain stimulation can be considered as a significant contribution to the treatment of severe Parkinson's disease However, in some patients it can induce overall cognitive decline or behavioural changes.